MDxHealth SA - Ordinary Shares (MDXH)

IRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee. Mr. Holder will take the seat of Regine Slagmulder, whose term completed in May.

Year-over-year Q1 revenues increase by 22% to $24.3 million71% year-over-year improvement in adjusted EBITDA in first quarterConference call with Q&A today at 4:30 PM ET / 22:30 CET

Fourth quarter revenue growth of 28% to $24.7 million2024 revenue growth of 28% to $90.0 million68% improvement in adjusted EBITDA in fourth quarterConference call with Q&A today at 4:30 PM EST / 22:30 CET

Company to Host Conference Call with Live Q&A, February 26, 2025, at 4:30pm ET / 22:30 CET

           

MDxHealth to Participate in Piper Sandler Healthcare Conference

MDxHealth to Present Third Quarter 2024 Financial Resultsand Corporate Update on November 6

MDxHealth Announces Pricing of Offering of Ordinary Shares

MDxHealth Announces Launch of Offering of Ordinary Shares

MDxHealth Reports Q2 and Half Year 2024 Results

MDxHealth to Present Second Quarter and First Half 2024 Financial Results

           

           

       

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results